Therapeutic Strategies Targeting Aerobic Glycolysis in Cancer and Dynamic Monitoring of Associated Metabolites
Open Access
Abstract
Cancer cells predominantly utilize aerobic glycolysis for energy production, preferentially converting glucose (Glu) to pyruvate (PA) and subsequently to lactate (LA). This metabolic reprogramming results in extracellular LA accumulation, acidifying the tumor microenvironment (TME) and facilitating tumor invasion and metastasis. The dynamics of Glu, PA, and LA are pivotal to tumor initiation and progression. This review comprehensively discussed therapeutic strategies targeting these key metabolites and systematically evaluates electrochemical and fluorescence-based techniques for their dynamic monitoring. We highlight the critical role of these monitoring approaches in advancing early cancer diagnosis, enabling personalized treatment, and accelerating anticancer drug development.Keywords
Funding Information
- Medical Science and Technology Project of Zhejiang Province (2023KY211, Y202454785)
- Scientific Research Fund of Zhejiang Provincial Education Department (2023KY211, Y202454785)
This publication has 182 references indexed in Scilit:
- Aberrant Energy Metabolism in Tumors and Potential Therapeutic TargetsGenes, Chromosomes and Cancer, 2024
- An Enzyme‐Loaded Metal–Organic Framework‐Assisted Microfluidic Platform Enables Single‐Cell Metabolite AnalysisAngewandte Chemie International Edition, 2023
- Lactate and pyruvate levels correlation with lactate dehydrogenase gene expression and glucose consumption in Tamoxifen‐resistant MCF‐7 cells using capillary electrophoresis with contactless conductivity detection (CE‐C4D)Electrophoresis, 2021
- Plant‐derived glucose transport inhibitors with potential antitumor activityPhytotherapy Research, 2019
- Benserazide is a novel inhibitor targeting PKM2 for melanoma treatmentInternational Journal of Cancer, 2019
- Small‐Molecule Inhibition of Glucose Transporters GLUT‐1–4ChemBioChem, 2019
- Synthesis of Indomorphan Pseudo‐Natural Product Inhibitors of Glucose Transporters GLUT‐1 and ‐3Angewandte Chemie International Edition, 2019
- Novel Multiplexed Biosensor System for the Determination of Lactate and Pyruvate in Blood SerumElectroanalysis, 2019
- Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapyCancer Medicine, 2018
- Cancer‐specific interruption of glucose metabolism by resveratrol is mediated through inhibition of Akt/GLUT1 axis in ovarian cancer cellsMolecular Carcinogenesis, 2014